Make Them In Europe: The French Solution To Drug Shortages
The French Senate has produced a set of recommendations for tackling the growing problem of medicine shortages in France and the rest of Europe. The industry body Leem says shortages have many causes and that it will work with other stakeholders to find long-term solutions.
You may also be interested in...
What is a medicines shortage? The answer may seem obvious, but the fact that European regulators have only now come up with a commonly agreed definition suggests otherwise.
France’s medicines and medical devices regulator wants to build up its role in the EU regulatory system, make its inner workings more accessible to stakeholders and the outside world, and improve the way it deals with medicine shortages.
Moving more manufacturing to the US could help increase supply chain reliability, which could prevent or blunt shortages, an industry representative argues.